vimarsana.com

Page 5 - Department Of Urology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UGN-102 With/Without TURBT Produces Similar DOR and DFS in Newly Diagnosed and Recurrent NMIBC

UGN-102 with/without TURBT displayed meaningful and similar DFS and DOR rates in newly diagnosed and recurrent low-grade intermediate-risk NMIBC.

New yorkUnited statesWilliamc huangLangone healthClinical affairsRobotics programGrossman school of medicineDepartment of urologyAmerican urological association annual meetingUrological association annualUgn 102Low grade intermediate risk nmibcF nyu grossman school of medicineAtlas trial

Dr Kutikov on Therapeutic Approaches in Urothelial Cancer Requiring Cystectomy

Alexander Kutikov, MD, FACS, discusses treatment options for patients with urothelial cancer requiring cystectomy.

Alexander kutikovRobertar schellerDepartment of urologyUrologic oncology at fox chase cancer centerUrologic oncologyFox chase cancer centerAua annual meetingUrothelial cancer

PSMA-PET Plus Multi-Parametric MRI Aids Detection of Clinically Significant Prostate Cancer

18F-DCFPyL PSMA-PET imaging plus multi-parametric MRI improved the detection of clinically significant prostate cancer in low- and high-risk men on active surveillance.

United statesMarcelo bigarellaDepartment of urologyInternational society of urological pathologistsPublic healthUniversity of wisconsin school medicineAmerican urological association annual meetingGrade groupUrological association annualWisconsin schoolInternational societyUrological pathologists

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer

/PRNewswire/ Johnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study evaluating the efficacy and safety of.

United kingdomUnited statesSan antonioAnia diantonioIndianj urolJoseph jacobPrnewswire johnsonClin urolJanssen research developmentAmerican cancer societyEuropean association of urologyEuropean society for medical oncologyBladder cancer advocacy networkDrug administrationNone of janssen research developmentExchange commission

Extended Lymphadenectomy Shows No DFS, OS Benefit During Radical Cystectomy in MIBC

Concurrent radical cystectomy and extended lymph node dissection did not show benefit vs standard lymph node dissection in muscle invasive urothelial cancer.

San antonioUnited statesBaylor college of medicineSethp lernerDave swalmDepartment of urologyAmerican urological association meetingAmerican urological association annual meetingUrological association annualDave swalm chairUrologic oncologyBaylor collegeUrological association meeting

vimarsana © 2020. All Rights Reserved.